Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

30. August 2011 07:30 ET | Quelle: EDAP TMS S.A.

EDAP Reports Second Quarter 2011 Financial Results

Second Quarter 2011 Highlights Received U.S. FDA 510(k) marketing clearance in August 2011 for Sonolith i-move device, a technologically advanced compact mobile lithotripter Obtained...
24. August 2011 08:30 ET | Quelle: EDAP TMS S.A.

EDAP Partnership Wins EUR 2.4 Million Grant for Development of Innovative Imaging Solution for Focal Treatment of Prostate Cancer

LYON, France, Aug. 24, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that its development partnership has been awarded a EUR 2.4...
03. August 2011 08:30 ET | Quelle: EDAP TMS S.A.

EDAP Gains U.S. FDA 510(k) Lithotripter Clearance

LYON, France, Aug. 3, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced it has received marketing clearance from the U.S. Food and Drug...
26. Juli 2011 08:30 ET | Quelle: EDAP TMS S.A.

EDAP Schedules Webcast and Conference Call of Second Quarter 2011 Results

LYON, France, July 26, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its second quarter 2011 results...
14. Juni 2011 09:37 ET | Quelle: EDAP TMS S.A.

EDAP Secures Market Clearance for Its Sonolith(R) Lithotripters in Major Asian Markets

-- Latest and Modular Model, Sonolith® i-move, is Now Approved in Japan -- -- Fully Integrated and Robotized Model, Sonolith® i-sys, is Approved in Taiwan -- LYON, France, June 14,...
25. Mai 2011 08:30 ET | Quelle: EDAP TMS S.A.

EDAP to Showcase Ablatherm(R) HIFU Data at 4th International Symposium on Focal Therapy & Imaging in Prostate & Kidney Cancer

LYON, France, May 25, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced two abstracts supporting the Ablatherm® High Intensity...
24. Mai 2011 07:30 ET | Quelle: EDAP TMS S.A.

EDAP Reports First Quarter 2011 Financial Results

First Quarter 2011 Highlights Lithotripsy division revenues increased 28.9% year-over-year to EUR 3.5 million (USD 4.9 million), fueled by innovative product line Gross profit increased...
12. Mai 2011 11:45 ET | Quelle: EDAP TMS S.A.

EDAP Features New Ablatherm(R) HIFU Data Supporting Superior Efficacy for Treatment of Local Prostate Cancer at American Urological Association Annual Meeting

LYON, France, May 12, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced Ablatherm® High Intensity Focused Ultrasound (HIFU) will be...
10. Mai 2011 09:37 ET | Quelle: EDAP TMS S.A.

EDAP Schedules Webcast and Conference Call of First Quarter 2011 Results

LYON, France, May 10, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its first quarter 2011 results announcement,...
09. Mai 2011 09:00 ET | Quelle: EDAP TMS S.A.

Published 15-Year Clinical Review Supports EDAP's Ablatherm(R) HIFU as Viable Primary Treatment for Local Prostate Cancer at Any Stage

LYON, France, May 9, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced a published 15-year clinical review of Ablatherm® HIFU data...

Vorherige Seite

Nächste Seite